24 results
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
, recruit and train additional qualified personnel. Due to our limited financial resources and the limited experience of our management team in managing … a company with such planned growth, we may not be able to effectively manage the expansion of our operations or recruit and train additional qualified
6-K
EX-99.2
MREO
Mereo Biopharma Group Plc
2 Nov 21
Current report (foreign)
4:16pm
;
A delay in the Company’s ability to further recruit patients to our clinical trials and to screen patients for eligibility for its clinical trials
F-3/A
MREO
Mereo Biopharma Group Plc
27 Sep 21
Shelf registration (foreign) (amended)
4:18pm
recruit patients to our clinical trials and to screen patients for eligibility for our clinical trials;
Interruption to key clinical trial activities … and recruit additional qualified personnel;
our ability to manage growth;
our ability to successfully integrate and realize the benefits of our past
F-3/A
8c03 vos2
7 Sep 21
Shelf registration (foreign) (amended)
4:06pm
F-3
zwc8y9sn58d4ap9 ti0e
5 Aug 21
Shelf registration (foreign)
4:33pm
6-K
EX-99.1
5gr64hr9hd7158 24hf
2 Jun 21
Current report (foreign)
8:24am
424B5
zkp5hgz 6kr7cx33
10 Feb 21
Prospectus supplement for primary offering
4:53pm
424B5
yojyj3rcqxayp
9 Feb 21
Prospectus supplement for primary offering
5:24pm
424B5
fns96g 4qttkxay
23 Oct 20
Prospectus supplement for primary offering
4:40pm
F-3
3tx7zeq45zdy36itwm1
6 Oct 20
Shelf registration (foreign)
4:25pm
F-3
wlavdnty
6 Jul 20
Shelf registration (foreign)
4:58pm
POS AM
v4dqn39jcbf l2
2 Jul 20
Prospectus update (post-effective amendment)
3:57pm
6-K
ek0ac bhoy9kpvzm9s8b
28 Apr 20
Current report (foreign)
4:10pm
F-1/A
uhiryf
12 Mar 20
Registration statement (foreign) (amended)
5:15pm
F-1/A
wsmb7
6 Mar 20
Registration statement (foreign) (amended)
5:32pm
F-1
x41wyqxs4xn
18 Feb 20
Registration statement (foreign)
5:15pm